pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 6,918 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
  • Marketed
    elafibranor
    Iqirvo (elafibranor)
    Primary Sclerosing Cholangitis Ipsen SA
  • Marketed
    elagolix sodium + estradiol + norethindrone + elagolix sodium
    Oriahnn (elagolix sodium + estradiol + norethindrone + elagolix sodium)
    Menorrhagia$ABBV AbbVie Inc.
  • Marketed
    elapegademase
    Revcovi (elapegademase-lvlr)
    Adenosine Deaminase (ADA) Deficiency Related SCID Leadiant Biosciences Inc
← prev
page 174 of 231
next →
131
Pain89
Neurology1
Marketed
elasomeran
Spikevax (elasomeran [INN])
Coronavirus Disease 2019 (COVID-19)
$MRNA Moderna, Inc.
  • Phase 3
    elebsiran
    elebsiran
    Hepatitis D$VIR Vir Biotechnology, Inc.
  • Phase 3
    elebsiran + tobevibart
    elebsiran + tobevibart
    Hepatitis D$VIR Vir Biotechnology, Inc.
  • Phase 2
    elecoglipron
    elecoglipron
    Type 2 Diabetes$AZN ASTRAZENECA PLC
  • Phase 3
    elegrobart
    elegrobart
    Graves' Ophthalmopathy Viridian Therapeutics Inc
  • Phase 3
    elenestinib
    elenestinib
    Systemic Mastocytosis Blueprint Medicines Corp
  • Preclinical
    elesclomol
    elesclomol
    Endometrial Cancer Edison Oncology Holding Corp
  • Marketed
    eletriptan hydrobromide
    Eletriptan Hydrobromide
    Migraine Beximco Pharmaceuticals USA Inc
  • Phase 2
    elezanumab
    elezanumab
    Traumatic Spinal Cord Injury$ABBV AbbVie Inc.
  • Phase 3
    elfucose
    elfucose
    Inherited Metabolic Disorders AUG Therapeutics LLC
  • Phase 2
    elifactant
    elifactant
    Neonatal Respiratory Distress Syndrome Chiesi Farmaceutici SpA
  • Marketed
    eliglustat tartrate
    Eliglustat Tartrate
    Gaucher Disease Type I Aizant Drug Research Solutions Pvt Ltd
  • Marketed
    elinzanetant
    Lynkuet (elinzanetant)
    Vasomotor Symptoms of Menopause (Hot Flashes) Bayer USA LLC
  • Phase 2
    elironrasib
    elironrasib
    Non-Small Cell Lung Cancer$RVMD Revolution Medicines, Inc.
  • Phase 2
    elisrasib
    elisrasib [INN]
    Solid Tumor D3 Bio Inc
  • Marketed
    elivaldogene autotemcel
    Skysona (elivaldogene autotemcel [INN])
    Adrenoleukodystrophy (X-Linked Adrenoleukodystrophy (X-ALD)) Genetix Biotherapeutics Inc
  • Marketed
    elosulfase alfa
    Vimizim (elosulfase alfa)
    Mucopolysaccharidosis IV (MPS IV) (Morquio Syndrome )$BMRN BIOMARIN PHARMACEUTICAL INC
  • Marketed
    elotuzumab
    Empliciti (elotuzumab)
    Refractory Multiple Myeloma Bristol-Myers Squibb Co
  • Phase 2
    elraglusib
    elraglusib
    Neuroblastoma$ACTU ACTUATE THERAPEUTICS, INC.
  • Phase 3
    elritercept
    elritercept
    Anemia$TAK TAKEDA PHARMACEUTICAL CO LTD
  • Phase 3
    elsunersen
    elsunersen [INN]
    Epileptic Encephalopathy$PRAX Praxis Precision Medicines, Inc.
  • Phase 1
    eltanolone
    eltanolone [INN]
    Epilepsy$LPCN Lipocine Inc.
  • Phase 2
    eltivutabart
    eltivutabart [INN]
    Pancreatic Ductal Adenocarcinoma Trishula Therapeutics Inc
  • Phase 2
    elunetirom
    elunetirom
    Bipolar I Disorder Autobahn Therapeutics Inc
  • Marketed
    eluxadoline
    Viberzi (eluxadoline)
    Diarrhea$ABBV AbbVie Inc.
  • Phase 2
    elzovantinib
    elzovantinib
    Non-Small Cell Lung Cancer Bristol-Myers Squibb Co
  • Phase 3
    emactuzumab
    emactuzumab
    Tenosynovial Giant Cell Tumor SynOx Therapeutics Ltd